FDA Inspection 1167413 — StimLabs, LLC
The FDA completed an inspection of StimLabs, LLC on Apr 7, 2022 in Roswell, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 7, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Roswell, GA (United States)